Development of a Droplet Digital Polymerase Chain Reaction Assay for the Sensitive Detection of Total and Integrated HIV-1 DNA

Overview

Journal Chin Med J (Engl)

Specialty General Medicine

Date 2024 Mar 4

PMID 38433332

Authors

Lin Yuan

Zhiying Liu

Xin Zhang

Feili Wei

Shan Guo

Na Guo

Lifeng Liu

Zhenglai Ma

Yunxia Ji

Rui Wang

Xiaofan Lu

Zhen Li

Wei Xia

Hao Wu

Tong Zhang

Bin Su

Affiliations

Soon will be listed here.

Abstract

Background: Total human immunodeficiency virus (HIV) DNA and integrated HIV DNA are widely used markers of HIV persistence. Droplet digital polymerase chain reaction (ddPCR) can be used for absolute quantification without needing a standard curve. Here, we developed duplex ddPCR assays to detect and quantify total HIV DNA and integrated HIV DNA.

Methods: The limit of detection, dynamic ranges, sensitivity, and reproducibility were evaluated by plasmid constructs containing both the HIV long terminal repeat (LTR) and human CD3 gene (for total HIV DNA) and ACH-2 cells (for integrated HIV DNA). Forty-two cases on stable suppressive antiretroviral therapy (ART) were assayed in total HIV DNA and integrated HIV DNA. Correlation coefficient analysis was performed on the data related to DNA copies and cluster of differentiation 4 positive (CD4 + ) T-cell counts, CD8 + T-cell counts and CD4/CD8 T-cell ratio, respectively. The assay linear dynamic range and lower limit of detection (LLOD) were also assessed.

Results: The assay could detect the presence of HIV-1 copies 100% at concentrations of 6.3 copies/reaction, and the estimated LLOD of the ddPCR assay was 4.4 HIV DNA copies/reaction (95% confidence intervals [CI]: 3.6-6.5 copies/reaction) with linearity over a 5-log 10 -unit range in total HIV DNA assay. For the integrated HIV DNA assay, the LLOD was 8.0 copies/reaction (95% CI: 5.8-16.6 copies/reaction) with linearity over a 3-log 10 -unit range. Total HIV DNA in CD4 + T cells was positively associated with integrated HIV DNA ( r = 0.76, P <0.0001). Meanwhile, both total HIV DNA and integrated HIV DNA in CD4 + T cells were inversely correlated with the ratio of CD4/CD8 but positively correlated with the CD8 + T-cell counts.

Conclusions: This ddPCR assay can quantify total HIV DNA and integrated HIV DNA efficiently with robustness and sensitivity. It can be readily adapted for measuring HIV DNA with non-B clades, and it could be beneficial for testing in clinical trials.

References

Yuan R, Cheng H, Chen L, Zhang X, Wang B . Prevalence of different HIV-1 subtypes in sexual transmission in China: a systematic review and meta-analysis. Epidemiol Infect. 2016; 144(10):2144-53. PMC: 9150594. DOI: 10.1017/S0950268816000212. View

Malatinkova E, Thomas J, De Spiegelaere W, Rutsaert S, Geretti A, Pollakis G . Measuring Proviral HIV-1 DNA: Hurdles and Improvements to an Assay Monitoring Integration Events Utilising Human Repeat Sequences. Life (Basel). 2021; 11(12). PMC: 8706387. DOI: 10.3390/life11121410. View

Chomont N, El-Far M, Ancuta P, Trautmann L, Procopio F, Yassine-Diab B . HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation. Nat Med. 2009; 15(8):893-900. PMC: 2859814. DOI: 10.1038/nm.1972. View

Finzi D, Hermankova M, Pierson T, Carruth L, Buck C, Chaisson R . Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy. Science. 1997; 278(5341):1295-300. DOI: 10.1126/science.278.5341.1295. View

Hindson C, Chevillet J, Briggs H, Gallichotte E, Ruf I, Hindson B . Absolute quantification by droplet digital PCR versus analog real-time PCR. Nat Methods. 2013; 10(10):1003-5. PMC: 4118677. DOI: 10.1038/nmeth.2633. View

Serrano-Villar S, Gutierrez C, Vallejo A, Hernandez-Novoa B, Diaz L, Abad Fernandez M . The CD4/CD8 ratio in HIV-infected subjects is independently associated with T-cell activation despite long-term viral suppression. J Infect. 2012; 66(1):57-66. DOI: 10.1016/j.jinf.2012.09.013. View

Mexas A, Graf E, Pace M, Yu J, Papasavvas E, Azzoni L . Concurrent measures of total and integrated HIV DNA monitor reservoirs and ongoing replication in eradication trials. AIDS. 2012; 26(18):2295-306. PMC: 4692807. DOI: 10.1097/QAD.0b013e32835a5c2f. View

Graf E, ODoherty U . Quantitation of integrated proviral DNA in viral reservoirs. Curr Opin HIV AIDS. 2013; 8(2):100-5. DOI: 10.1097/COH.0b013e32835d8132. View

Piketty C, Weiss L, Assoumou L, Burgard M, Melard A, Ragnaud J . A high HIV DNA level in PBMCs at antiretroviral treatment interruption predicts a shorter time to treatment resumption, independently of the CD4 nadir. J Med Virol. 2010; 82(11):1819-28. DOI: 10.1002/jmv.21907. View

10.

Abdel-Mohsen M, Richman D, Siliciano R, Nussenzweig M, Howell B, Martinez-Picado J . Recommendations for measuring HIV reservoir size in cure-directed clinical trials. Nat Med. 2020; 26(9):1339-1350. PMC: 7703694. DOI: 10.1038/s41591-020-1022-1. View

11.

Pollack R, Jones R, Pertea M, Bruner K, Martin A, Thomas A . Defective HIV-1 Proviruses Are Expressed and Can Be Recognized by Cytotoxic T Lymphocytes, which Shape the Proviral Landscape. Cell Host Microbe. 2017; 21(4):494-506.e4. PMC: 5433942. DOI: 10.1016/j.chom.2017.03.008. View

12.

Chun T, Stuyver L, Mizell S, Ehler L, Mican J, Baseler M . Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy. Proc Natl Acad Sci U S A. 1997; 94(24):13193-7. PMC: 24285. DOI: 10.1073/pnas.94.24.13193. View

13.

Guardo A, Zarama A, Gonzalez T, Bargallo M, Rojas J, Martinez E . Effects on immune system and viral reservoir of a short-cycle antiretroviral therapy in virologically suppressed HIV-positive patients. AIDS. 2019; 33(6):965-972. DOI: 10.1097/QAD.0000000000002169. View

14.

Siliciano J, Siliciano R . Enhanced culture assay for detection and quantitation of latently infected, resting CD4+ T-cells carrying replication-competent virus in HIV-1-infected individuals. Methods Mol Biol. 2005; 304:3-15. DOI: 10.1385/1-59259-907-9:003. View

15.

Massanella M, Richman D . Measuring the latent reservoir in vivo. J Clin Invest. 2016; 126(2):464-72. PMC: 4731179. DOI: 10.1172/JCI80567. View

16.

Ishak A, AlRawashdeh M, Esagian S, Nikas I . Diagnostic, Prognostic, and Therapeutic Value of Droplet Digital PCR (ddPCR) in COVID-19 Patients: A Systematic Review. J Clin Med. 2021; 10(23). PMC: 8658157. DOI: 10.3390/jcm10235712. View

17.

Chen J, Zhou T, Zhang Y, Luo S, Chen H, Chen D . The reservoir of latent HIV. Front Cell Infect Microbiol. 2022; 12:945956. PMC: 9368196. DOI: 10.3389/fcimb.2022.945956. View

18.

Zhang X, Wang X, Qin L, Lu X, Liu Z, Li Z . Changing roles of CD3 + CD8 low T cells in combating HIV-1 infection. Chin Med J (Engl). 2022; 136(4):433-445. PMC: 10106209. DOI: 10.1097/CM9.0000000000002458. View

19.

Taylor J, Fahey J, Detels R, Giorgi J . CD4 percentage, CD4 number, and CD4:CD8 ratio in HIV infection: which to choose and how to use. J Acquir Immune Defic Syndr (1988). 1989; 2(2):114-24. View

20.

Chung H, Hattler J, Narola J, Babbar H, Cai Y, Abdel-Mohsen M . Development of Droplet Digital PCR-Based Assays to Quantify HIV Proviral and Integrated DNA in Brain Tissues from Viremic Individuals with Encephalitis and Virally Suppressed Aviremic Individuals. Microbiol Spectr. 2022; 10(1):e0085321. PMC: 8754137. DOI: 10.1128/spectrum.00853-21. View